Cargando…

Human recombinant soluble ACE2 in severe COVID-19

Detalles Bibliográficos
Autores principales:	Zoufaly, Alexander, Poglitsch, Marko, Aberle, Judith H, Hoepler, Wolfgang, Seitz, Tamara, Traugott, Marianna, Grieb, Alexander, Pawelka, Erich, Laferl, Hermann, Wenisch, Christoph, Neuhold, Stephanie, Haider, Doris, Stiasny, Karin, Bergthaler, Andreas, Puchhammer-Stoeckl, Elisabeth, Mirazimi, Ali, Montserrat, Nuria, Zhang, Haibo, Slutsky, Arthur S, Penninger, Josef M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2020
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7515587/ https://www.ncbi.nlm.nih.gov/pubmed/33131609 http://dx.doi.org/10.1016/S2213-2600(20)30418-5

Ejemplares similares

Successful management of the first reported case in Austria of COVID-19 with ARDS
por: Seitz, T., et al.
Publicado: (2020)

Diagnosis of COVID-19 using multiple antibody assays in two cases with negative PCR results from nasopharyngeal swabs
por: Traugott, Marianna Theresia, et al.
Publicado: (2020)

COVID-19-associated myoclonus in a series of five critically ill patients
por: Grieb, Alexander, et al.
Publicado: (2021)

Clinical and Angiographic Features in Three COVID-19 Patients with Takotsubo Cardiomyopathy. Case Report
por: Hoepler, Wolfgang, et al.
Publicado: (2021)

Detection of bacteria via multiplex PCR in respiratory samples of critically ill COVID-19 patients with suspected HAP/VAP in the ICU
por: Karolyi, Mario, et al.
Publicado: (2021)

Comparison of clinical characteristics among patients infected with alpha vs. delta SARS-CoV-2 variants
por: Rumpf, Benedikt, et al.
Publicado: (2022)

Diagnostik und Therapie von COVID-19 auf der Intensivstation
por: Hoepler, Wolfgang, et al.
Publicado: (2022)

Assessment of S1-, S2-, and NCP-Specific IgM, IgA, and IgG Antibody Kinetics in Acute SARS-CoV-2 Infection by a Microarray and Twelve Other Immunoassays
por: Semmler, Georg, et al.
Publicado: (2021)

High Dose Lopinavir/Ritonavir Does Not Lead to Sufficient Plasma Levels to Inhibit SARS-CoV-2 in Hospitalized Patients With COVID-19
por: Karolyi, Mario, et al.
Publicado: (2021)

COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria
por: Pawelka, Erich, et al.
Publicado: (2021)

Correction to: COVID-19 is not “just another flu”: a real-life comparison of severe COVID-19 and influenza in hospitalized patients in Vienna, Austria
por: Pawelka, Erich, et al.
Publicado: (2021)

Heterogeneous SARS-CoV-2-Neutralizing Activities After Infection and Vaccination
por: Graninger, Marianne, et al.
Publicado: (2022)

Late onset pulmonary embolism in young male otherwise healthy COVID-19 patients
por: Karolyi, M., et al.
Publicado: (2020)

Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease Severity
por: Koblischke, Maximilian, et al.
Publicado: (2020)

Tocilizumab vs. baricitinib in hospitalized severe COVID-19 patients: results from a real-world cohort
por: Karolyi, Mario, et al.
Publicado: (2022)

Monkeypox associated acute arthritis
por: Fonti, Mirella, et al.
Publicado: (2022)

Rapid Detection of Bacterial and Fungal Pathogens Using the T2MR versus Blood Culture in Patients with Severe COVID-19
por: Seitz, Tamara, et al.
Publicado: (2022)

Early administration of remdesivir may reduce mortality in hospitalized COVID-19 patients: A propensity score matched analysis
por: Karolyi, Mario, et al.
Publicado: (2022)

Hydroxychloroquine versus lopinavir/ritonavir in severe COVID-19 patients: Results from a real-life patient cohort
por: Karolyi, Mario, et al.
Publicado: (2020)

The Role of Bacterial and Fungal Superinfection in Critical COVID-19
por: Seitz, Tamara, et al.
Publicado: (2022)

Is there a clinical difference between influenza A and B virus infections in hospitalized patients?: Results after routine polymerase chain reaction point-of-care testing in the emergency room from 2017/2018
por: Karolyi, Mario, et al.
Publicado: (2019)

Deletion of the NKG2C receptor encoding KLRC2 gene and HLA-E variants are risk factors for severe COVID-19
por: Vietzen, Hannes, et al.
Publicado: (2021)

Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 Infections
por: Medits, Iris, et al.
Publicado: (2022)

Camostat Mesylate Versus Lopinavir/Ritonavir in Hospitalized Patients With COVID-19—Results From a Randomized, Controlled, Open Label, Platform Trial (ACOVACT)
por: Karolyi, M., et al.
Publicado: (2022)

The natural killer cell‐associated rs9916629‐C allele is a novel genetic risk factor for fatal COVID‐19
por: Vietzen, Hannes, et al.
Publicado: (2022)

Renin-angiotensin system inhibitor discontinuation in COVID-19 did not modify systemic ACE2 in a randomized controlled trial
por: Rathkolb, Vincent, et al.
Publicado: (2023)

Evaluation of Five Commercial SARS-CoV-2 Antigen Tests in a Clinical Setting
por: Seitz, Tamara, et al.
Publicado: (2022)

ACE2 Elevation in Severe COVID-19
por: Reindl-Schwaighofer, Roman, et al.
Publicado: (2021)

Percutaneous Auricular Vagus Nerve Stimulation Reduces Inflammation in Critical Covid-19 Patients
por: Seitz, Tamara, et al.
Publicado: (2022)

Randomized controlled study to evaluate the safety and clinical impact of percutaneous auricular vagus nerve stimulation in patients with severe COVID-19
por: Seitz, Tamara, et al.
Publicado: (2023)

Molecular diagnosis of autochthonous human anaplasmosis in Austria – an infectious diseases case report
por: Hoepler, Wolfgang, et al.
Publicado: (2020)

Human soluble ACE2 improves the effect of remdesivir in SARS‐CoV‐2 infection
por: Monteil, Vanessa, et al.
Publicado: (2020)

115. Evaluation of the Clinical Impact of the T2MR for the Diagnosis of Bloodstream Infections
por: Seitz, Tamara, et al.
Publicado: (2019)

SARS-CoV-2 Pre-Exposure Prophylaxis with Sotrovimab and Tixagevimab/Cilgavimab in Immunocompromised Patients—A Single-Center Experience
por: Totschnig, David, et al.
Publicado: (2022)

Successful treatment of intubation-induced severe neurogenic post-extubation dysphagia using pharyngeal electrical stimulation in a COVID-19 survivor: a case report
por: Traugott, Marianna, et al.
Publicado: (2021)

Correction: A case of fulminant respiratory diphtheria in a 24-year-old Afghan refugee in Austria in May 2022: a case report
por: Traugott, M. T., et al.
Publicado: (2023)

A case of fulminant respiratory diphtheria in a 24-year-old Afghan refugee in Austria in May 2022: a case report
por: Traugott, M. T., et al.
Publicado: (2022)

Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target
por: Zhang, Haibo, et al.
Publicado: (2020)

Inhibition of SARS-CoV-2 Infections in Engineered Human Tissues Using Clinical-Grade Soluble Human ACE2
por: Monteil, Vanessa, et al.
Publicado: (2020)

Evidence in favor of the essentiality of human cell membrane-bound ACE2 and against soluble ACE2 for SARS-CoV-2 infectivity
por: Batlle, Daniel, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_3dp45rkl29uacucapsv0r1pksp